Although deletions involving CREBBP were only observed in approximately 6% of GBM, the CREBBP locus was frequently hypermethylated in human GBMs, and for 9 tumors this was correlated with a significant down-regulation of mRNA expression (i.e. epigenetic silencing). Here, CREBBP is linked to glioblastoma.